New cancer clinical trial: Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Published on: October 31, 2018 at 12:00PM
Condition:   Overall Survival
Intervention:   Drug: Irinotecan,Oxaliplatin, and S1
Sponsor:   Qingdao Central Hospital
Recruiting
https://ift.tt/2RtBA13